Skip to content

Development of a novel ultrashort pulse CO2 fractional laser system

Development of a novel ultrashort pulse CO2 fractional laser system

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037367
Enrollment
Unknown
Registered
2020-08-28
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

scar

Interventions

Laser treatment group:Ultrashort pulse fraction laser therapy
Laser test group:Ultrashort pulse fraction laser

Sponsors

Xinhua Hospital, School of Medicine, Shanghai Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 18-55 years old adults, donors without diabetes, hypertension and other chronic basic diseases. No surgical, laser, radiation or chemical therapy has been performed in the surgical / laser treated area. There was no tissue infection and congenital malformation in the operation area.

Exclusion criteria

Exclusion criteria: Patients with keloid history, isotretinoin, oral anticoagulant use history, patients with chronic underlying diseases, or pregnancy, inflammation or infection, surgery, laser, radiation or chemical treatment in the surgical area, or congenital malformation.

Design outcomes

Primary

MeasureTime frame
height;Scar hardness;Surface smoothness of scar;Scar area;

Countries

China

Contacts

Public ContactLyu Kaiyang

Department of Plastic Surgery, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University

lvkaiyang@hotmail.com+86 13816938691

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026